Acadia Pharmaceuticals (ACAD) Operating Leases (2019 - 2026)
Acadia Pharmaceuticals (ACAD) recorded Operating Leases of $59.55 million in Q2 2026, up 33.5% from $44.6 million a year earlier and up 52.7% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals reported Operating Leases of $40.55 million, down 3.5% from FY2024.
- Annual Operating Leases has declined for four straight years, with a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $42.04 million in FY2024 (-12.1%), $47.8 million in FY2023 (-9.3%), $52.7 million in FY2022 (-6.1%) and $56.13 million in FY2021 (+26.2%).
- The Q2 2026 figure is the highest quarterly Operating Leases since Q1 2021.
- On a year-over-year basis, Operating Leases rose in two of the last eight quarters, with an average decline of 2.4%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 33.5% in Q2 2026, against a decline of 16.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $39 million (Q1 2026), $40.55 million (Q4 2025) and $43.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.51 Bn | 36.36 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.55 Mn |
| Mar 31, 2026 | 39.00 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 43.03 Mn |
| Jun 30, 2025 | 44.60 Mn |
| Mar 31, 2025 | 44.63 Mn |
| Dec 31, 2024 | 42.04 Mn |
| Sep 30, 2024 | 40.42 Mn |
| Jun 30, 2024 | 47.19 Mn |
| Mar 31, 2024 | 49.19 Mn |
| Dec 31, 2023 | 47.80 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 49.78 Mn |
| Mar 31, 2023 | 51.44 Mn |
| Dec 31, 2022 | 52.70 Mn |
| Sep 30, 2022 | 53.77 Mn |
| Jun 30, 2022 | 54.69 Mn |
| Mar 31, 2022 | 55.48 Mn |
| Dec 31, 2021 | 56.13 Mn |
| Sep 30, 2021 | 57.68 Mn |
API Access
Acadia Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();